Zhou, S.; Hassan, A.; Kungyal, T.; Tabariès, S.; Luna, J.L.R.G.; Siegel, P.M.; Philip, A.
CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells. Cancers 2022, 14, 3672.
https://doi.org/10.3390/cancers14153672
AMA Style
Zhou S, Hassan A, Kungyal T, Tabariès S, Luna JLRG, Siegel PM, Philip A.
CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells. Cancers. 2022; 14(15):3672.
https://doi.org/10.3390/cancers14153672
Chicago/Turabian Style
Zhou, Shufeng, Amani Hassan, Tenzin Kungyal, Sebastien Tabariès, José Luis RamÃrez GarcÃa Luna, Peter M. Siegel, and Anie Philip.
2022. "CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells" Cancers 14, no. 15: 3672.
https://doi.org/10.3390/cancers14153672
APA Style
Zhou, S., Hassan, A., Kungyal, T., Tabariès, S., Luna, J. L. R. G., Siegel, P. M., & Philip, A.
(2022). CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells. Cancers, 14(15), 3672.
https://doi.org/10.3390/cancers14153672